Gene · 10399
Papers3,110
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,110
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SMYD3 synergises with RACK1 to promote colorectal cancer lung metastasis by recruiting SMAD3. | Cell Commun Signal | 2026 | 41634833 | PubTator, text mining | PubMed |
| Engineering an orthogonal ubiquitin transfer cascade with RING E3 RNF38 by phage display to reveal its regulation of nuclear transport. | J Biol Chem | 2026 | 41581872 | PubTator, text mining | PubMed |
| Host-Directed Antiviral Activity of SB2960 Through Selective Induction and Remodeling of Stress Granules. | Adv Sci (Weinh) | 2026 | 41532664 | PubTator, text mining | PubMed |
| USP49 regulates lipid metabolism in hepatocellular carcinoma by stabilizing RACK1 to promote tumor proliferation and migration. | Biochim Biophys Acta Mol Cell Res | 2026 | 41519241 | PubTator, text mining | PubMed |
| Proteomic analysis of plant interactors with the RNA silencing suppressor V2 encoded by croton yellow vein mosaic virus. | Virology | 2026 | 41380400 | PubTator, text mining | PubMed |
| Loss of GNB2L1 promotes expansion of CD74+ dendritic cells and contributes to development of diabetic foot ulcers. | Mol Immunol | 2026 | 41344082 | PubTator, text mining | PubMed |
| Cancer-Associated Fibroblasts Promote Imatinib Resistance in Gastrointestinal Stromal Tumors through PGK1-Mediated Metabolic Reprogramming. | Cancer Res | 2026 | 41270149 | PubTator, text mining | PubMed |
| ZAK activation at the collided ribosome. | Nature | 2026 | 41261136 | PubTator, text mining | PubMed |
| Selective PPAR-α activation with pemafibrate attenuates macrophage-mediated progression of calcific aortic valve disease. | bioRxiv | 2025 | 41446100 | PubTator, text mining | PubMed |
| DENetwork unveils non-differentially expressed genes with functional relevance across conditions through information flow perturbation. | Nucleic Acids Res | 2025 | 41404797 | PubTator, text mining | PubMed |
| A Duality of Function: An Integrative Model of RACK1 as a Switch Between Translational and Signaling Hubs. | Int J Mol Sci | 2025 | 41373878 | PubTator, text mining | PubMed |
| Ribosomal Architecture and rRNA Modification Landscape in the Tick-Borne Parasite Babesia divergens. | bioRxiv | 2025 | 41293005 | PubTator, text mining | PubMed |
| A moonlighting function of tumoral interleukin-1β precursor promotes metastasis via RACK1-mediated actin remodeling. | Nat Commun | 2025 | 41257838 | PubTator, text mining | PubMed |
| The xCT/CD98 complex suppresses ferroptosis in pan-cancer via a non-canonical RACK1-mediated iron homeostasis pathway. | Cell Rep | 2025 | 41252251 | PubTator, text mining | PubMed |
| Targeting MET Signalling Activated by CPNE3-RACK1 Interaction Through VWFA Domain to Suppress Lung Cancer Progression. | J Cell Mol Med | 2025 | 41190648 | PubTator, text mining | PubMed |
| Molecular mechanisms of RACK1-driven metastasis in pancreatic ductal adenocarcinoma revealed by single-cell RNA sequencing. | Discov Oncol | 2025 | 41105310 | PubTator, text mining | PubMed |
| Targeting PARylated RACK1/HIF-1α axis: A novel mechanism in acute kidney injury and therapeutic promise. | Acta Pharm Sin B | 2025 | 41049756 | PubTator, text mining | PubMed |
| Toxicological Impacts of Polypropylene Nanoparticles Similar in Size to Nanoplastics in Plastic-Bottle Injections on Human Umbilical Vein Endothelial Cells. | Toxics | 2025 | 41012423 | PubTator, text mining | PubMed |
| Profiling of terminating ribosomes reveals translational control at stop codons. | bioRxiv | 2025 | 41000726 | PubTator, text mining | PubMed |
| Catalpol: An Iridoid Glycoside With Potential in Combating Cancer Development and Progression-A Comprehensive Review. | Phytother Res | 2025 | 40985933 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10399/papers?page=3